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Abstract 
    Evans’ oxazolidinones are among the most well-established and extensively used chiral 
auxiliaries for stoichiometric asymmetric methods in total synthesis. The most common 
applications are α-alkylation and syn-aldol reactions, which build either enantiomers or 
diastereomers containing flexible function groups for further elaboration. Fluorous quasiracemic 
synthesis involves synthesis of both enantiomers of a target compound in a single synthesis by 
implementation of a fluorous tagging strategy. Here, two different fluorous-tagged 
oxazolidinones were synthesized in an efficientt synthetic strategy. Preliminary alkylation and 
aldol condensation of the fluorous-tagged imides derived from the corresponding oxazolidinones 
were carried out and compared with the non fluorous-tagged imide in the aspect of yield and 
diastereomer ratios. The alkylation and aldol reactions of the quasiracemic mixture were 
conducted and the resultant crude products were subjected to HPLC analysis. 
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Chapter 1  Introduction 
 
1.1 Chiral Auxiliaries 
A chiral auxiliary is an optically active chemical compound or unit that is temporarily 
incorporated into an organic synthesis so that it can transfer chirality, with predictable 
stereochemistry in newly formed stereocenters. Chiral auxiliaries introduce chirality in otherwise 
achiral compounds and then in the following reaction step, induce the asymmetric formation of a 
second stereocenter with steric hindrance as a driving force. After the creation of the second 
stereocenter, the original auxiliaries can be removed and recycled. Chiral auxiliaries were 
introduced by E.J. Corey in 1978 with chiral 8-phenylmenthol1 and by B.M. Trost in 1980 with 
chiral mandelic acid.2 The menthol compound is difficult to prepare and an alternative is trans-2-
phenyl-1-cyclohexanol, introduced by J. K. Whitesell in 1985.3  
Ideally a stoichiometric chiral auxiliary must be easy to attach efficiently to the substrate, 
control completely the stereoselectivity in reactions of the attached substrate and be readily 
removed. If the chiral auxiliary is very inexpensive (e.g. α-methylbenzylamine) it can be 
destroyed in the cleavage step; however, for most chiral auxiliaries an efficient recycling 
procedure should be a prerequisite for use. 
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1.2 Evans’ Oxazolidinones 
   Evans’ oxazolidinones (exemplified by 1 and 2) are among the most well-established and 
extensively used chiral auxiliaries for stoichiometric asymmetric methods in total synthesis.4 The 
most common applications are α-alkylation and syn-aldol reactions, which build either 
enantiomers or diastereomers containing flexible function groups for further elaboration. And the 
reliable and easily scaleable reaction procedure for these types of transformations contribute to 
the popularity of Evans’ oxazolidinones in organic synthesis.5 Other applications of Evans’ 
oxazolidinones involving anti-aldol reactions, Michael addition, addition to C=O and C=N bonds 
and cycloaddtion etc. have been also investigated and developed.5,6 Also a variety of new 
auxiliaries that evolved from Evans’ oxazolidinones, have come forth and been applied in 
asymmetric synthesis.5 Removal of the oxazolidinone auxiliaries with no occurrence of 
racemization or epimerization has been achieved and also the auxiliaries can be efficiently 
recycled.5,6 
We designed a pair of derivatives of Evans’ oxazolidinones and investigated the reactivity and 
stereoselection of these derivatives in alkylation and aldol reactions. Compound 3 is one of these 
derivatives and a perfluorinated group Rf is attached to the oxazolidinone ring by oxyphenyl 
group. Before the introduction of our studies on these derivatives, I provide an overview of the 
preparation, N-acylation, alkylation, syn-aldol reactions and cleavage of Evans’ oxazolidinone 
auxiliaries. 
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1.2.1 Preparation of Oxazolidinones  
The general methods to make oxazolidinones 4 with various substituents (R1, R2, R3 and R4) 
at C4 and C5 positions start from the corresponding amino alcohols 5 (scheme 1). R5 can be a 
proton (5a) or an acyl group (5b).  
Scheme 1 
NHO
O
R1
R2
R4
R3
HO
NH
R2 R1
R3 R4
4 5
R5
45
5a, R5 =  H
5b, R5 =  Boc, EtOC(O), PhOC(O)
 
In the case of 5a, phosgene was initially used to combine the amino and alcohol groups by 
carbonyl group to provide oxazolidinones 4.7 Triphosgene often serves as the source of phosgene 
because it is easier to handle and less dangerous due to its solid state.8  
The N-protected amino alcohol 5b itself bears the carbonyl group on nitrogen atom, so here 
an external carbonyl source for the five-membered oxazolidinone ring is unnecessary. The 
transformation of 5b into 4 can be conducted in a mild and safe reaction condition by using 
thionyl chloride (SOCl2, THF, Eq. 1),9 potassium carboxylate (K2CO3, toluene, Eq. 2)10 or 
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potassium t-butoxide (t-BuOK, THF, Eq. 3).11  
 
NH
HO
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R
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O
R
NH
HO
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O
R
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O
R
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(Eq. 3)
(Eq. 2)
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HO
O
O
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THF
NHO
O
Ar Ar
(Eq. 1)
 
 
1.2.2 N-Acylation Reaction 
The first step for oxazolidinone auxiliary to operate in asymmetric synthesis is the attachment 
of the substrate to the chiral auxiliary, which is typically achieved by an N-acylation reaction. 
Butyllithium and an acid chloride or anhydride (mixed or symmetrical) of the substrate12 are 
generally employed, but the excess butyllithium might cause epimerization at the C5 position of 
the oxazolidinone ring through a dianion intermediate.13  
A mild, simple and efficient process for the N-acylation without inconvenience of 
epimerization was reported by David Ager and co-workers.14 This reaction involved treatment of 
the oxazolidinone with 2-5 mol% DMAP, 1.0 equiv of triethylamine and 1.0-2.0 equiv of acid 
chloride, mixed or symmetric anhydride of a large variety of substrates at room temperature or at 
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reflux (scheme 2). This reaction results in a large variety of N-acylated oxazolidinone and should 
extend well to more complex substrates. 
Scheme 2 
NHO
O
R2
R1
R3
+
R4 R5
O cat. DMAP, NEt3
NO
O
R2
R1
R3
R4
O
 
 
 
 
 
 
 
1.2.3 Alkylation 
An intensive investigation of utility of enolates derived from N-acylated oxazolidinone in 
asymmetric alkylation was disclosed in the communication of Evans and co-workers.15 The 
general reaction conditions involved treatment of the N-acylated oxazolidinone with LDA or 
NaHMDS in THF at -78 oC followed by addition of alkylating agent at 0 oC (scheme 3).     
As illustrated from their experimental data, the complementary levels of diastereoface 
selection of alkylation reaction could be deduced from the enolates of 6 and 7 (scheme 3). Less 
reactive (non-allylic/benzylic) electrophiles require the use of sodium enolates or triflate as 
leaving group.15 
 
R1 R2 R3 R4 R5 
1 Ph H H Me  
2 H Me Ph Et OC(O)R4,OC(O)Bu-
t,Cl 
3 t-Bu H H OBu-t  
4 CH2C6H11-c H H C5H11-n  
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Scheme 3 
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O
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R1X
major
major
minor 8
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7
4
4
 
Evans interpreted that Z-enolates were formed with very high selectivity and then the 
electrophiles tended to attack from the opposite face to the chiral controlling group at C4 position 
of oxazolidinone ring, which is exemplified in Scheme 4.15 
The diastereoselection of Evans’ oxazolidinone auxiliary in alkylation reactions has been 
acknowledged in many examples and the stereochemistry of the major product can be reliably 
assigned by the model in Scheme 4. 
Scheme 4 
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O O
4
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O O
4
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N O
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4
Li
BnBr
NO
O O
4
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1.2.4 Aldol Condensation 
   Evans and co-workers used the boron enolates that were derived from the corresponding N-
propionylimides 6 and 7 in aldol addition (scheme 5). And high enantioselectivity (E1 vs. E2 or T1 
vs. T2) and diastereoselection (E1 + E2 vs. T1 + T2) were observed for the aldol reaction (Eq. 4).16 
Scheme 5 
6
7
NO
O
NO
O
Ph Me
10
R1
O
R1
O
Me
OH
Me
OH
11
NO
O O
NO
O
Ph Me
O
Bu2BOTf
R1CHO
Bu2BOTf
R1CHO
R1
Me2CH6
7
E1:E2
Me2CH
497:1
<1:500
yield, %
10, 78
11, 91
C6H5CHO6
7
>500:1
<1:500
10, 88
11, 89C6H5CHO
 
 
Xc
O
Me + R1CHO
Xc R1
O
Me
OH
Xc R1
O
Me
OH
Xc R1
O
Me
OH
Xc R1
O
Me
OH
E1 T1
E2 T2
(Eq. 4)
 
    
 
It was observed that both 6 and 7 formed the (Z)-enolates (Z:E ≥ 100) with high 
                                                                                                    8  
stereoselectivity when treated with either LDA (THF, -78 oC) or Bu2BOTf. But high 
stereoselectivity in the aldol reaction was obtained for boron enolate and low stereoselection was 
observed for lithium enolate.13 Evans suggested that boron enolates undergo aldol reactions via a 
chair-like cyclohexane transition state: R group is apart from the enolate π-face to minimize 
dipole-dipole interaction within the imide; R1 group in pseudo-equatorial position to avoid the 
steric interaction with the butyl ligand on boron (scheme 6).17 On the contrary, lithium enolates 
may go through the cyclohexane transition state in either way where R1 group can be in either 
pseudo-equatorial or -axial position since lithium metal center does not bear exo-ligands. 
Scheme 6 
R
NO
OO
4
CH3
Bu
n-Bu n-Bu
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R
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OB(n-Bu)2O
4
CH3
O
B
O
N
O
O
n-Bu
n-Bu
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R1
H
CH3
R
H
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O
B
O
N
O
O
n-Bu
n-Bu
H
R1
H
CH3
H
R
unfavored
R1CHO
R
NO
OO
R1
CH3
OH
R
NO
OO
R1
CH3
OH
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The amount of Bu2BOTf is important to the syn-diastereoselectivity of these aldol reactions. 
Heathcock and co-workers reported their observation of anti-dominated product 12 by treatment 
of 7 with 2 equiv of Bu2BOTf.18  
NO
O O
Ph
Method A, B or C NO
O O
Ph
OH
NO
O O
Ph
OH
+
7 12 13  
 
There have been many other applications of Evans’ oxazolidinones, including highly 
diastereoselective asymmetric acylation reactions,19 asymmetric hydroxylation,20 
diastereoselective aldol condensation of β-keto imide,21 Michael addition,22 addition to C=O and 
C=N bonds,20 cycloaddtion, etc.23  
1.2.5 Cleavage of the Oxazolidinone Auxiliaries 
Two types of cleavage of oxazolidinones have been observed: exocyclic cleavage and 
endocyclic cleavage. The exocyclic cleavage is usually desired but endocyclic cleavage occurs 
when the oxazolidinone derived carboximides 14 bear bulky R1 group (scheme 8).24  
 
 
 
 Bu2BOTf  
(equiv) 
Hünigs Base 
 (equiv) 
CH3CHO 
 (equiv) 
R2AlCl  
(equiv) 
 
12:13 
12  
(Yield, %) 
A 1.1 1.15 2.0 3.0 2.5:1 60 
B 2.0 1.15 1.25 - 7:1 50-70 
C 2.0 1.15 1.25 - 7:1 79 
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Scheme 7 
NO
O
R
R1
O
NHO
O
R
R1
O
HO
HNHO
R
R1
O
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NHO
O
R
R1HO
14
15
17
19
16
18
OH−
H−
OH−, or H−
 
Lithium hydroxide is the common reagent for the transformation of 14 into 15 and 16, but 
sometimes undesired endocyclic cleavage occurs. This can be avoided by using lithium 
hydroperoxide instead.25 The cleavage by using lithium boron (or aluminum) hydride reductively 
removes the auxiliary to form the alcohol 18.26 These two methods are among the most common 
ones to remove the oxazolidinone 15 with no racemization or epimerization. 
All the above studies concerning Evans’ oxazolidinones have already been investigated well, 
applied widely in organic synthesis and been the basis of the studies on the derivatives of Evans’ 
oxazolidinones, such as superquat auxiliaries,27 polymer-attached oxazolidinones,28 and also the 
perfluorinated oxazolidinone derivatives designed by us. The perfluorinated group plays a crucial 
role in the application of our oxazolidinone derivatives to quasiracemic synthesis that will be 
introduced in the following. 
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1.3 Quasiracemic Synthesis 
Fluorous quasiracemic synthesis was introduced by Curran30 and it involves synthesis of both 
enantiomers of a target compound in a single synthesis by implementation of a fluorous tagging 
strategy.  
   The strategy of fluorous quasiracemic synthesis is shown in Scheme 9. Enantiomers R-20 and 
S-20 are attached with different fluorous groups T1 and T2 that contain perfluoroalkyl groups as 
tags to provide R-21a and S-21b. T1 differs from T2 only in fluorine content, so R-21a and S-21b 
are quasienantiomers. R-21a and S-21b are mixed to make a quasiracemic mixture M-21a/b, 
which is then taken through a series of steps to make a final tagged product mixture M-22a/b. All 
the tagged molecules are typically soluble in common organic solvents.30 
Scheme 8 
R-20
S-20
T1
T2
R-21a
S-21b
R-SM
S-SM
R-SM- T1
S-SM- T2
1. Tag 2. Mix
(R,S)-SM- T's
M-21a/b
3. Synthesis
(R,S)-P- T's
M-22a/b
synthetic steps
R-P- T's
R-22a
T's
S-22b
S-P-
4. Separation 5. Detag
R-P
S-P
R-23
S-23  
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The mixture M-22a/b is then separated by fluorous HPLC (F-HPLC) on FluoroFlashTM 
column that is selective based on the fluorine content to provide the two pure quasienantiomers 
R-22a and S-22b. The tags are finally removed to generate the two true enantiomers R-23 and S-
23.  
   The F-HPLC column contains a stationary phase of Si(Me)2CH2CH2C8F17 and has a strong and 
selective retention of fluorous compounds. Molecules with longer fluorinated chains have longer 
retention times on the column.31 A typical mobile phase for F-HPLC is a gradient of MeOH-H2O 
with increasing MeOH up to 100%. Other solvents such as MeCN or THF can be used to replace 
MeOH for the gradient elution. Isocratic elution using the above solvents also works well for 
some samples. 
   Our group has employed the fluorous quasiracemic synthesis to make both enantiomers of 
mappicine (scheme 10).30 Quasienantiomers R-25a and S-25b were provided by stereoselective 
reduction of ketone 24 followed by silylization with silyl bromides bearing -(CH2)2C6F13 and -
(CH2)2C8F17 groups as tags, respectively. The quasienantiomers R-25a and S-25b behave like true 
enantiomers when subjected to the typical spectroscopic analyses (1H and 13C NMR) and 
chromatographic techniques (flash chromatography). R-25a and S-25b were then mixed in 
equimolar amounts for the four-step quasiracemic synthesis to provide quasiracemic mixture of 
protected mappicines M-26a/b. This mixture was then separated by fluorous chromatography to 
provide pure R-26a and S-26b. Deprotection of resolved quasienantiomers provided R-mappicine 
and S-mappicine, respectively. 
                                                                                                    13  
Scheme 9 
N
N
O
HO
N
N
O
HO
(R)-mappicine
(S)-mappicine
N
OMe
TMS
O
Si(iPr)2CH2CH2C6F13N
OMe
TMS
O
1. (+)-DIP chloride
2. BrSi(iPr)2CH2CH2C6F13
1. (−)-DIP chloride
2. BrSi(iPr)2CH2CH2C8F17
N
OMe
TMS
O
Si(iPr)2CH2CH2C8F17
N
OMe
TMS
O
Si(iPr)2CH2CH2Rf
Mix
1. ICl
2. BBr3
3. HCCCH2Br
4. PhCN
N
N
O
RfCh2Ch2(Pri)2SiO
demixing by
fluorous chromatography
N
N
O
C6F13H2CH2C(Pri)2SiO
N
N
O
C8F17H2CH2C(Pri)2SiO
detagging
24
R-25a
S-25b
M-25a/b
M-26a/b
R-26a
S-26b  
  
A fluorous quasiracemic synthesis should be considered when both enantiomers are needed 
for structure identification, biological testing, or any other aim.  
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Chapter 2  Synthesis of Quasienantiomeric Fluorous-Tagged Oxazolidinones 
      and Application in Alkylation and syn-Aldol Reactions 
 
2.1 Design of Quasienantiomeric Fluorous-Tagged Oxazolidinones 
 
R-27a
S-27b
ORf6
NHO
O
ORf8
NHO
O
R-27a, Rf6 = CH2CH2CH2C6F13
S-27b. Rf8 = CH2CH2CH2C8F17
4
4
R-27
NHO
O
4
NHO
O
4
OCH2CH2CH2C6F13+
A B
S-27
NHO
O
4
NHO
O
4
OCH2CH2CH2C8F17
+
C D
 
Figure 1 Structure of quasiracemic fluorous-tagged oxazolidinones R-27a and S-27b 
 
We designed a pair of quasienantiomeric fluorous-tagged oxazolidinones R-27a and S-27b 
(Figure 1), each of which is composed of two parts: One part is phenyloxazolidinone core, which 
is labeled as A for R-27a and C for S-27b; the other part is perfluoroalkylpropyloxy group with B 
for R-27a and D for S-27b. The core structure A of R-27a is derived from the commonly used 
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auxiliary 4R-phenyloxazolidin-2-one R-27.32 Meanwhile, the core structure C of S-27a is derived 
from S-27, the enantiomer of R-27. The fluorous group B (3-perfluorohexylpropyl-1-oxy) differs 
from D (3-perfluorooctylpropyl-1-oxy) in fluorine content. Accordingly, while R-27 and S-27 are 
true enantiomers, R-27a and S-27b are quasienantiomers. Based on this structure association, it 
was expected that R-27a (S-27b) would exhibit similar reactivity and stereoselection to R-27 (S-
27) in the same alkylation and syn-aldol reactions. The suffixes “a” and “b” following a 
compound name designate the fluorous tag group: “a” series, perfluorohexylpropyl 
(C6F13CH2CH2CH2-); “b” series, perfluorooctylpropyl (C8F17CH2CH2CH2-). The prefixes R- or 
S- before numbers indicate the R- or S-enriched enantiomer at C4 position of oxazolidinone ring.  
The reactivity and stereoselectivity of the fluorous-taged oxazolidinones R-27a (S-27b) in 
alkylation and aldol reactions are compared to those of the non fluorous-tagged counterpart R-27 
(S-27), which is one of our two aims. The other aim is to apply a mixture (a quasiracemate) of 
quasienantiomers R-27a and S-27b (1:1) to the same alkylation and aldol reactions and the 
resultant mixture is subjected to F-HPLC analysis. Since S-27 is the enantiomer of R-27, it must 
have the same reactivity and stereoselection as R-27. Therefore we chose only R-27 as the 
substrate for the non-fluorous control reaction.   
Imide R-28 is derived from the corresponding oxazolidinones R-27 and it undergoes 
alkylation reaction with R1Br (Eq. 5) and aldol condensation with R2CHO (Eq. 6). Similarly, the 
imides derived from fluorous-tagged oxazolidinones R-27a and S-27b are also employed in the 
reactions (Eq. 5 and Eq. 6). The yield and the diastereomer ratio of the product for each imide are 
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compared to another one to reach the first aim.  
 
R-27
NHO
O
4
NO
O
4
4R1X
R2CHO
(Eq. 5)
(Eq. 6)
O
NO
O O
R1
NO
O
4
O
R2
Me
OH
R-28
LHMDS
Bu2OTf
 
 
For the second aim, quasienantiomeric imides R-28a and S-28b are prepared from the 
quasienantiomers R-27a and S-27b and then mixed to afford a quasiracemic mixture M-28a/b 
(prefix M means quasiracemic mixture), as shown in Figure 2. M-28a/b undergoes alkylation or 
aldol condensation to afford a mixture M-29a/b that involves the crude product R-29a from R-
28a and S-29b from S-28b. Then M-29a/b is subjected to analysis by F-HPLC. Since R-29a and 
S-29b have different fluorine content, they elute from the F-HPLC column in different retention 
time. By F-HPLC analysis of the reaction crude products of quasiracemate M-28a/b, individual 
imides R-28a and S-28b, we can see the difference between quasiracemic synthesis and single 
reaction. 
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NO
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O
S-28b
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NO
O
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O
M-28a/b
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O
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O
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M-29a/b
  one mixture of 
  crude products 
R-29a and S-29b
crude product
     R-29a
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     S-29b
1. Mix 3. Analysis by     F-HPLC
 
Figure 2 Strategy of the reactions of the quasiracemate M-28a/b 
 
2.2 Synthesis of Quasienantiomeric Fluorous-Tagged Oxazolidinones 
The synthesis of R-27a and S-27b was achieved over five steps, as shown in Scheme 10. 
Esterification of commercially available D-4-hydroxyphenylglycine R-30 in the presence of 
thionyl chloride and methanol afforded crude amino ester R-31. It showed good purity by 1H 
NMR spectroscopic analysis and so the crude product was directly used for the next step. 
Treatment of R-31 with Boc anhydride (Boc2O) and NaHCO3 in dioxane/water provided the 
crude Boc amino ester R-32, which was condensed with 3-perfluorohexylpropan-1-ol in 
Mitsunobu conditions33 (DEAD and TPP) to provide fluorous-tagged Boc amino acid R-33a in  
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Scheme 10 
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88% isolated yield34 (85% yield over three steps). Starting from L-4-hydroxyphenylglycine S-30, 
esterification, Boc protection and Mitsunobu reaction by using 3-perfluorooctylpropan-1-ol were 
conducted to afford S-33b in 86% overall yield.34 
Reduction of R-33a (S-33b) by LAH (THF, 0 °C) provided Boc amino alcohol R-34a (S-34b) 
in isolated yield of 90% (81%).34 Treatment of R-34a (S-34b) with thionyl chloride (THF, 0 °C) 
afforded fluorous-tagged oxazolidinone R-27a (S-27b) in isolated yield of 82% (78%).34 In this 
reaction, the Boc group of R-34a (S-34b) was the source of carbonyl group at C2 position of the 
five-member oxazolidinone ring of R-27a (S-27b).  
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It was observed that R-27a and S-27b had identical 1H NMR and 13C NMR spectra. But the 
optical rotation values of these two compounds in CHCl3 were opposite in sign and different in 
magnitude: R-27a, [α]20D    −6.08 (c = 0.17); S-27b, [α]20D   +16.78 (c = 0.13). The similarity in the 
properties of 1H NMR and 13C NMR spectroscopy, and different magnitude in optical rotation 
values were also observed for quasienantiomers R-33a and S-33b, R-34a and S-34b. Table 1 lists 
the optical rotation values for these four compounds.  
 
Table 1 Optical rotation values of R-33a, S-33b, R-34a and S-34b in CHCl3. 
compound [α]20D   (c) 
R-33a -19.12 (0.19) 
S-33b +42.53 (0.87) 
R-34a -16.82 (2.53) 
S-34b +18.10 (2.50) 
 
To ensure that racemization of an amino ester intermediate did not occur prior to reduction of 
the esters R-33a and S-33b, we conducted experiments to measure the enantiopurity of amino 
alcohols R-34a and S-34b. Mosher ester derivatives (R)-MTPA-R-35a and (R)-MTPA-S-35b 
(Figure 3) were prepared by treatment of R-34a and S-34b with (R)-α-methoxy-α-
(trifluoromethyl)-phenylacetic chloride in the presence of DMAP (CH2Cl2).  
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Figure 3 Mosher esters (R)-MTPA-R-35a and (R)-MTPA-S-35b 
 
While the quasienantimeric amino alcohols R-34a and S-34b exhibited identical 
characteristics of proton NMR spectroscopy, the separation of several proton NMR signals of 
Mosher esters (R)-MTPA-R-35a and (R)-MTPA-S-35b was observed, as expected for 
quasidiastereomers. The 1H NMR spectrum of (R)-MTPA-R-35a was compared to  
 
C6H2 C6H2
CH3
A
B
                                                        
Figure 4 300 MHz 1H NMR spectra: A. (R)-MTPA- R-35a; B. 1:1 mixture of (R)-MTPA-R-35a 
and (R)-MTPA-S-35b    
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that of a mixture of these two Mosher esters, as shown in Figure 4. The separation of the proton 
signals of (R)-MTPA-R-35a and (R)-MTPA-S-35b are obvious in the phenyl protons at C2 
position and in the methyl protons. 
Correspondingly, the different chemical shifts between these two Mosher esters are listed in 
Table 2, here ∆δ equals to chemical shift δ35b minus δ35a. Proton NMR signals for only one 
diastereomer were found for (R)-MTPA-R-35a and also for (R)-MTPA-S-35b. So both the amino 
alcohols R-34a and S-34b have 100% ee. The transformation of R-34a (S-34b) into 
oxazolidinone R-27a (S-27b) occurred without breaking the bonds connecting to the stereocenter 
at C2 position, so R-27a (S-27b) is assumed to be enantiopure compounds.     
Table 2 The different chemical shift between (R)-MTPA-R-35a and (R)-MTPA-S-35b. 
  δ (ppm)   
 2H (meta to ORf) 2H (ortho to ORf ) OMe ee (%) 
(R)-MTPA-R-35a 6.85, 6.83 7.20, 7.17 3.45 100 
(R)-MTPA-S-35b 6.85, 6.84 7.19, 7.16 3.47 100 
∆δ (ppm) 0.00, 0.01 −0.01, −0.01 0.02  
 
2.3 N-Acylation of the Quasienantiomeric Fluorous-Tagged Oxazolidinones 
   N-Propionyl oxazolidinone R-28 was afforded by treatment with oxazolidinone R-27 with 
DMAP (10 mol%), 3 equiv of Et3N and 2 equiv of propionic anhydride (THF, r. t.), followed by 
purification by flash chromatography in 92% yield34 (scheme 11). Fluorous-tagged imides R-28a 
and S-28b was formed through the same synthesis and were isolated in 86% and 80% yields.34 As 
the former quasienantiomer pairs, R-28a and S-28b have identical characteristics of 1H NMR and 
13C NMR spectroscopy. The optical rotation values of these two compounds in CHCl3 are shown 
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in Table 3.  
Scheme 11 
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4
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O
4
2 DMAP (10 mol%), Et3N (3 equiv),
  propionic anhydride  (2 equiv),
                   THF, r.t.
R-28, 92%R-27  
 
Table 3 Optical rotation values of R-28a and S-28b in CHCl3. 
 R-28a S-28b 
[α]20D   (c) -27.00 (0.20) +18.61 (0.18) 
 
 
2.4 Alkylations and syn-aldol reactions of imides R-28, R-28a and S-28b 
The diastereoselective alkylations and syn-aldol reactions of the enolates derived from imides 
R-28, R-28a and S-28b and comparison of the reactivity and stereoselection of the two fluorous-
tagged oxazolidinone auxiliaries with the non-fluorous one are disclosed in this section.     
Scheme 12 shows the diastereoselective alkylation process. The alkylation involved treatment 
of the imide R-28 (R-28a, S-28b) in THF with 1.5 equiv of lithium bis(trimethylsilyl)amide 
(LHMDS, 1.0 M in THF) at −78 °C to provide the lithium enolate, followed by treatment with 3 
equiv of benzyl bromide at −78 °C. Both of the major and monor diastereomer products were 
isolated by flash chromatography. The N-deacylation of the imide was found to concur with the  
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Scheme 12a 
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a Conditions: (a) LHMDS; (b) BnBr 
alkylation reaction and the oxazolidinone R-27 (R-27a, S-27b) was obtained. Also there was a 
small amount of starting material recovered. 
For the control alkylation of R-28, the minor product R-37 has been reported in literature.35 
Since only two diastereomers can be provided, we are sure of the structure of the major product 
R-36. These results also accord with the diastereoselection of the alkylation of the imides derived 
from Evans’ oxazolidinones.15 In the cases of R-28a and S-28b, we compared the separation of 
the proton signals of the major and minor products with that of R-28 and found that they are 
similar. So R-36a and R-37a were assumed as the major and minor products of R-28a 
respectively, and S-37b and S-36b as the major and minor ones of S-28b. 
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The alkylation studies are summarized in Table 4. For each imide, diastereomer ratio (entries 
A-C) was obtained from the 1H NMR spectrum of crude alkylation product. A number of trends 
are evident from the data in the table. First, the similar yields of major products of R-28 (62%34), 
R-28a (58%34) and S-28b (60%34) indicated that the fluorous-tagged imides R-28a and S-28b 
exhibited similar reactivity to the non fluorous-tagged imide R-28. Second, R-28 (R-36:R-37 ≥ 
95:5), R-28a (R-36a:R-37a ≥ 93:7) and S-28b (S-37b:S-36b ≥ 92:8) underwent highly 
diastereoselective alkylation with BnBr. F-HPLC analysis of the crude product of the fluorous-
tagged imides R-28a (S-28b) via UV light clearly showed the components in the mixture: 
diastereomeric products (not separable), deacylation product and unreacted imide.  
 
Table 4. Stereoselective alkylation of the enolates derived from imides R-28, R-28a and S-28b. 
 
Imide 
diastereomer 
ratioa 
main diastereomer 
isolated yield of, %b
isolated compounds 
ratios c 
HPLC analysis ratios d 
R-28 R-36:R-37  
≥ 95:5 
R-36, 62%      R-36:R-27:R-28 
15:3:1 
- 
R-28a R-36a:R-37a 
≥ 93:7 
R-36a, 58% R-36a:R-27a:R-28a 
13:5:1 
R-36a:R-27a:R-28a 
14:2:1 
S-28b S-37b:S-36b  
≥ 92:8 
S-37b, 60% S-37b:S-27b:S-28b 
6:3:1 
S-37b:S-27b:S-28b 5:1:1
a Diastereomer ratios were determined by integration of the relevant signals in the 300 MHz 1H NMR 
spectra of crude product corresponding to the C4 protons at the five-membered oxazolidinone rings of major 
and minor diastereomers; both of the diastereomers were separated by flash chromatography. b Yields are 
calculated after flash chromatography. c Ratios were determined by calculation of the weight of main 
diastereomer, N-deacylation product and recovered imide, which were isolated by flash chromatography. d 
Ratios were determined by integration of the area of corresponding peaks in F-HPLC spectra of crude product.  
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Then we conducted the aldol condensation of the boron enolates of R-28 (R-28a, S-28b) 
(scheme 13). The general condition was enolization of the imide with 1.2 equiv of dibutylboryl 
triflate (Bu2OTf, 1.0 M in CH2Cl2) in the presence of diisopropylethylamine (DIPEA, 1.3 equiv) 
at 0 °C, followed by condensation with 1.5 equiv of hydrocinnamaldehyde (PhCH2CH2CHO) at 
−78 °C. Only one diastereomer R-3834 (R-38a34, S-39b34) and unreacted starting material were 
obtained after flash chromatography. The ratio of the product and the recovered imide was 
determined by the isolated weight. The crude aldol reaction products of R-28a and S-28b were 
also subjected to F-HPLC analysis. All these results are summarized in Table 5.  
Scheme 13  
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Table 5. Stereoselective aldol condensation of the boron enolates derived from imides R-28, R-
28a and S-28b. 
 
imide 
syn-isomer 
isolated yield of, %a 
recovered imide 
isolated yield of, %a 
HPLC analysis 
ratios b 
R-28 R-38,  81% 7% - 
R-28a R-38a, 38% 55% R-28a:R-38a 1:1 
S-28b S-39b, 53% 40% S-28b: S-39b 1:2 
  a Yields were obtained after flash chromatography. b Ratios were determined by integration of the area of corresponding peaks in 
F-HPLC spectrum of crude product. 
 
Surprisingly we observed that both of the aldol condensation of the fluorous substrates R-28a 
(38%) and S-28b (53%) afforded syn-products in much lower yields than the non-fluorous 
substrate R-28 (81%); 55% of R-28a and 40% of S-28b were recovered by flash chromatography. 
The F-HPLC chromatogram of the crude product of R-28a (S-28b) showed two main peaks that 
were identified as the syn-product and unreacted imide by co-injection of the pure isolated 
product and imide with the crude product, respectively.  
The optimistic point is that few by-products were generated for the fluorous substrates R-28a 
and S-28b and that the recovered imides can be recycled. The yields of R-38a (84%) and S-39b 
(88%) based on the recovered starting materials were good. Also the diastereoselectivety of R-
28a and S-28b were not affected by the fluorous tags. So R-28a and S-28b can still be applied in 
aldol reaction. These preliminary studies on alkylation and aldol condensation provided a basis 
for the subsequent quasiracemic synthesis. 
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2.5 Alkylation and Aldol Condensation of Quasiracemic Mixture of R-28a and S-28b 
A quasiracemic mixture M-28a/b of imides R-28a and S-28b (1:1) underwent alkylation with 
BnBr in the same conditions as we used for the individual imides to provide a mixture of crude 
products. It has been mentioned that resolution of the fluorous-tagged mixture can be achieved by 
fluorous chromatography. So the reaction mixture of M-28a/b directly eluted from 
FluoroFlashTM column by an isocratic MeCN:H2O 9:1 and was analyzed via UV light. We used 
the same conditions to analyze the crude alkylation product of individual fluorous-tagged imide. 
The F-HPLC chromatograms of the crude alkylation products of M-28a/b, R-28a and S-28b are 
all shown in Figure 5.  
S-27b
S-28b
S-37b and S-36b
1. M-28a/b
2. R-28a
R-27a
R-28a
R-36a and R-37a
S-27b
S-28b
    S-37b and S-36b
unknown
unknown
unknown
R-27a
R-28a R-36a and R-37a
unknown
3. S-28b
 
Figure 5 F-HPLC analysis of alkylation reaction: 1. M-28a/b; 2. R-28a; 3.S-28b. 
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The F-HPLC analysis of crude alkylation products of R-28a (S-28b) shows four peaks which 
are corresponding to deacylation product, starting material (imide), two unseparable 
diastereomeric products and a small unkown peak in the sequence of increasing retention time. 
Each of the former three peaks was identified by co-injection of the pure compound 
corresponding to this peak with the crude product to the F-HPLC column. The area ratios of the 
four peaks in the sequence of increasing retention time are 11:4:74:11 for R-28a and 13:13:61:13 
for S-28b. The two fluorous parts (Rf6 and Rf8) were separated by about 4 min. The F-HPLC 
analysis of the crude alkylation product of M-28a/b shows two pairs of four peaks in two 
separable ranges of retention time. The crude product of R-28a was co-injected with that of M-
28a/b and the resultant chromatogram shows that the four peaks of R-28a overlap with the four 
peaks (retention time: 4-6 min; area ratios: 14:14:58:14 in the sequence of increasing retention 
time) of M-28a/b. Meanwhile, the four peaks of S-28b overlap with the other four peaks 
(retention time: 10-12 min; area ratios: 17:17:49:17) of M-28a/b. So the two pairs of four peaks 
of M-28a/b are corresponding to the alkylation product of R-28a and that of S-28b, respectively. 
These F-HPLC analyses elucidate that the alkylation reaction of the quasiracemic mixture M-
28a/b with benzyl bromide is similar to that of the individual quasienantiomer imide. R-28a and 
S-28b show more similarity to each other in the alkylation of the quasiracemate than in that of the 
individual quasienantiomer. The separation of two fluorous parts (Rf6 and Rf8) of the crude 
product of M-28a/b on F-HPLC column by about 4 min is enough to resolve the two parts. 
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The boron enolate of M-28a/b was condensed with hydrocinnamaldehyde and the crude 
product was directly subjected to F-HPLC chromatography analysis via UV light (MeCN:H2O 
90:10, isocratic). The F-HPLC analysis of the crude product of individual quasienantiomer imide 
was conducted in the same condition. Figure 6 shows the resultant three chromatograms of the 
crude products of M-28a/b, R-28a and S-28b. The chromatogram for R-28a (S-28b) shows two 
major peaks that were identified as the aldol product and the remained imide by co-injection. The 
aldol product eluted faster than the imide on the fluorous column. The area ratios of these two 
peaks are 50:50 for R-28a and 67:33 for S-28b in the sequence of increasing retention time. The  
 
1. M-28a/b
2. R-28a
3.S-28b
R-38a
R-28a
S-39b
S-28b
 
Figure 6 F-HPLC analysis of aldol reaction: 1. M-28a/b; 2. R-28a; 3. S-28b. 
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chromatogram of M-28a/b shows two pairs of two peaks. The pair (retention time: 4-6 min; area 
ratio: 67:33 in the sequence of increasing retention time) corresponds to the crude product of R-
28a and the other pair ((retention time: 10-12 min; area ratio: 67:33) is the crude product of S-
28b. As the alkylation with BnBr, the aldol condensation of the quasiracemate M-28a/b with 
hyrdrocinnamaldehyde is similar to that of the individual quasienantiomer imide. R-28a and S-
28b show more similarity to each other in the aldol reaction of the quasiracemate than in that of 
the individual imide. The separation of the two fluorous parts (Rf6 and Rf8) of the crude aldol 
product of M-28a/b on F-HPLC column is about 4 min, which is similar to the alkylation reaction. 
These studies indicate that the reactivity and stereoseletion of the quasiracemic mixture of R-
28a and S-28b is similar to the individual imide. The advantage of the quasiracemic synthesis is: 
It can provide both of the enantiomers in a single reaction.  
2.6 Conclusion 
In summary, two different fluorous-tagged oxazolidinones were synthesized in an efficientt 
synthetic strategy. Preliminary alkylation and aldol condensation of the fluorous-tagged imides 
derived from the corresponding oxazolidinones were carried out and exhibited as good 
diastereoselectivety as the non fluorous-tagged imide. In the case of yield of aldol reaction, the 
fluorous-tagged imides showed big difference with the non-fluorous tagged one. The alkylation 
and aldol reactions of the quasiracemic mixture were conducted and showed similar reactivity 
and diastereoselection to the same reactions of individual imide. 
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Chapter 3 Experimental 
General. Toluene, THF, dichloromethane and diethyl ether were purified by filtration through 
activated alumina under an nitrogen atmosphere. Other reagents were used as they were received  
from Aldrich. 1H and 13C NMR spectra were recorded on Bruker Avance DPX 300 (300 MHz), 
Avance DRX 500 (500 MHz) and Avance 600 (600 MHz) spectrometers. CDCl3 was used as the 
NMR solvent unless otherwise noted. Infrared spectra were taken on a Mattson Genesis Series 
FTIR using thin film deposition on NaCl plates. Low resolution mass spectra were obtained on a 
Fision Autospec and reported in m/e units. High resolution mass spectra were obtained on a VG 
70-G or VG-Autospec double focusing instrument under EI mode. Optical rotations were 
measured on a Perkin-Elmer 241 polarimeter at the Na D-line (λ = 589 nm) using a 1 dm cell at 
20 ºC. HPLC analyses were conducted by using Waters 600 controller and Waters 2487 dual λ 
absorbance detector. Thin layer chromatography (TLC) was performed on silica gel 60 F254 
glass backed plates with a layer thickness of 0.25 mm manufactured by E. Merck. Flash 
chromatography was performed on silica gel (230-400 mesh ASTM) purchased from Sorbtech or 
Bodman. 
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R-33a 
(R)-N-(t-Butoxycarbonyl)-4-hydroxyphenylglycine methyl ester (32): D-4-Hydro- 
xyphenylglycine R-30 (3.00 g, 17.96 mmol) was suspended in methanol (60 mL) and thionyl 
chloride (2.4 ml, 32.89 mmol) was added dropwise via syringe over 10 min. The mixture was 
stirred for about 12 h at room temperature and the solvent was evapored under vacuum. The 
residue was washed twice with ether and the organic layer was dried (MgSO4) and concentrated 
to yield crude white solid D-4-hydroxyphenylglycine methyl ester R-31 (3.25 g) as a 
hydrochloride salt that was used in the next step without purification (see ref. 36). 
1H NMR (300 MHz, DMSO) δ 9.86 (s, 1H), 8.79 (s, 3H), 7.28 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 
8.5 Hz, 2H), 5.15 (s, 1H), 3.71 (s, 3H). 
To a mixture of crude D-4-hydroxyphenylglycine methyl ester R-31 (3.25g, 17.00 mmol) and 
NaHCO3 (2.268 g, 27 mmol) in H2O (38 mL) was added Boc anhydride (4.70 g, 21.53 mmol) in 
dioxane (38 mL) at 0 ºC. The mixture was stirred for 1 h at 0 °C and then 6 h at room temperature. 
After it was acidified with 1N HCl to approximately pH 2, the mixture was extracted with ethyl 
acetate (3 x 75 mL). The organic layer was combined, washed with H2O and brine and dried 
(MgSO4). The solvent was removed by rotary evaporation to yield crude (R)-N-(t-
butoxycarbonyl)-4-hydroxylphenylglycine R-32 (4.98 g) which was used directly without further 
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purification (see ref. 36). 
1H NMR (300 MHz, CDCl3) δ 7.18 (d, J = 7.8 Hz, 2H), 6.75 (d, J = 8.2 Hz, 2H), 5.63 (d, J = 6.8 
Hz, 1H), 5.24 (d, J = 6.8 Hz, 1H), 3.71 (s, 3H), 1.44 (s, 9H). 
(R)-N-(t-Butoxycarbonyl)-4-[(3-perfluorohexyl)propyl-1-oxy]phenylglycine methyl ester (R-
33a): To a solution of crude R-32 (1.30 g, 4.63 mmol), 3-(perfluorohexyl)propanol (2.63 g, 6.96 
mmol) and triphenyphosphine (1.84 g, 7.02 mmol) in THF (13 mL) was added a solution of 
DEAD (1.35 g, 6.98 mmol) in THF (13 mL) dropwise over 30 min and the mixture was stirred at 
room temperature for about 16 h. The mixture was concentrated and the residues were purified by 
column chromatography (4:1 hexanes/EtOAc) to yield the product R-33a (2.65 g, 90%) as 
colorless oil:  
[α]20D -19.12 (c = 0.19, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 8.6 Hz, 2H), 6.89 (d, J 
= 8.6 Hz, 2H), 5.53 (d, J = 6.0 Hz, 1H), 5.28 (d, J = 7.1 Hz, 1H), 4.05 (t, J = 5.8 Hz, 2H), 3.72 (s, 
3H), 2.34 (m, 2H), 2.13 (m, 2H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 171.8, 158.6, 154.8, 
129.5, 128.4 (2C), 114.8 (2C), 80.1, 66.3, 57.0, 52.6, 28.3 (3C), 27.9, 20.5; IR (NaCl) 3434, 2928, 
2930, 1747, 1715, 1613, 1513, 1209, 1055, 1028; LRMS (ES+) 664 (M + Na+); HRMS (ES+) 
Calcd. for C23H24NNaO5F13 (M + Na+) 664.1345. Found 664.135. 
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                               S-33b 
(S)-N-(t-Butoxycarbonyl)-4-[(3-perfluorooctyl)propyl-1-oxy]phenylglycine methyl ester (S-
33b): The procedure to make S-32b (overall yield in three steps, 86%) is the same as R-32a, 
starting from L-4-hydroxy-phenyl- glycine and perfluorooctylpropanol. 
[α]20D +42.53 (c = 0.87, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 8.7 Hz, 2H), 6.89 (d, J 
= 8.7 Hz, 2H), 5.52 (d, J = 6.3 Hz, 1H), 5.21 (d, J = 7.1 Hz, 1H), 4.05 (t, J = 5.8 Hz, 2H), 3.72 (s, 
3H), 2.34 (m, 2H), 2.14 (m, 2H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 171.8, 158.6, 154.8, 
129.5, 128.4 (2C), 114.8 (2C), 80.1, 66.3, 57.0, 52.6, 28.3 (3C), 27.9, 20.5; IR (NaCl) 3380, 2980, 
1715, 1612, 1587, 1369, 1055, 1028, 834, 721, 704, 655; LRMS (ES+) 764 (M + Na+); HRMS 
(ES+) Calcd. for C25H24NNaO5F17 (M + Na+) 764.1281. Found 764.127. 
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R-34a 
(R)-N-(t-Butoxycarbonyl)-4-[(3-perfluorohexyl)propyl-1-oxy]phenylglycinol (R-34a): To a 
solution of R-33a (2.00 g, 3.12 mmol) in THF (20 mL) was added LAH (0.36 g, 9.36 mmol) in 5 
MeO
NHBoc
O C8F17
O
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portions at 0 ºC and the mixture was stirred for 2 h. The reaction was quenched by careful 
addition of sat. aq. NH4Cl at 0 °C. 0.3M HCl (3.5 mL) was added and the mixture was filtered 
through celite. The filtered residue was rinsed with ether and the filtrate was extracted with ether 
(3 x 10 ml). The organic layer was combined, washed with brine and dried (MgSO4) and 
concentrated. Purification by column chromatography (1:1 hexanes/EtOAc) provided R-34a (1.70 
g, 90 %) as pale yellow oil: 
[α]20D -16.82 (c = 2.53, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.23 (d, J = 8.6 Hz, 2H), 6.88 (d, J 
= 8.6 Hz, 2H), 5.37 (bs, 1H), 4.70 (bs, 1H), 4.03 (t, J = 5.8 Hz, 2H), 3.76 (bs, 2H), 2.36 (m, 2H), 
2.13 (m, 2H), 1.42 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 158.1, 156.2, 132.1, 127.8 (2C), 114.6 
(2C), 79.9, 66.7, 66.3, 56.3, 28.3 (3C), 27.9, 20.5; IR (NaCl) 3367, 2979,, 2935, 2876, 1693, 
1613, 1513, 1478, 1454, 1392, 1367, 1243, 1205, 1145, 1052, 1028, 696; LRMS (ES+) 636 (M + 
Na+); HRMS (ES+) Calcd. for C22H24NNaO4F13 (M + Na+) 636.1395. Found 636.140. 
 
HO
NHBoc
O C8F17   
S-34b 
(S)-N-(t-Butoxycarbonyl)-4-[(3-perfluorooctyl)propyl-1-oxy]phenylglycinol (S-34b): 
[α]20D +18.10 (c = 2.50, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.24 (d, J = 8.6 Hz, 2H), 6.89 (d, J 
= 8.6 Hz, 2H), 5.29 (bs, 1H), 4.71 (bs, 1H), 4.04 (t, J = 5.8 Hz, 2H), 3.79 (bs, 2H), 2.34 (m, 2H), 
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2.14 (m, 2H), 1.43 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 158.1, 156.2, 132.1, 127.8 (2C), 114.6 
(2C), 79.9, 66.7, 66.3, 56.3, 28.3 (3C), 27.9, 20.5; IR (NaCl) 3374, 2979, 2873, 1688, 1614, 1514, 
1369, 1244, 1205, 1150, 1057, 1027, 991, 640; LRMS (ES+) 736 (M + Na+); HRMS (ES+) Calcd. 
for C24H24NNaO4F17 (M + Na+) 736.1332. Found 736.134. 
 
O
NHBoc
O
O
Ph
CF3MeO
(CH2)3C6F13  
                                (R)-MTPA-R-35a 
(R)-N-(t-Butoxycarbonyl)-4-[(3-perfluorohexyl)propyl-1-oxy]phenylglycinyl (R)-α-methoxy 
-α-(trifluoromethyl)phenyl acetate ester ((R)-MTPA-R-35a): To a mixture of R-34a (0.025 g, 
0.041 mmol), DMAP (0.010 g, 0.084 mmol) in CH2Cl2 (1 mL) was added a solution of (R)-α-
methoxy-α-(trifluoromethyl)phenylacetic chloride (0.026 g, 0.092 mmol) in CH2Cl2 (1 mL) 
dropwise at room temperature. The reaction mixture was stirred overnight and then concentrated. 
Purification by column chromatography (4:1 hexanes/EtOAc) provided (R)-MTPA-R-35a 
(0.025mg, 76%) as white solid: 
1HNMR (600 MHz, CDCl3) δ 7.42-7.34 (m, 5H), 7.19 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.6 Hz, 
2H), 4.98 (bs, 1H), 4.94 (bs, 1H), 4.53 (d, J = 8.4, 2H), 4.04 (t, J = 5.9 Hz, 2H), 3.45 (s, 3H), 
2.35-2.28 (m, 2H), 2.13-2.09 (m, 2H), 1.42 (s, 9H). 
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(R)-MTPA-S-35b 
(S)-N-(t-Butoxycarbonyl)-4-[(3-perfluorooctyl)propyl-1-oxy]phenylglycinyl (R)-α-Methoxy- 
α-(trifluoromethyl)phenyl acetate ester ((R)-MTPA-S-35b): 
1H NMR (600 MHz, CDCl3) δ 7.42-7.34 (m, 5H), 7.18 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.6 Hz, 
2H), 5.01 (bs, 1H), 4.94 (bs, 1H), 4.56 (d, J = 8.4, 2H), 4.04 (t, J = 5.8 Hz, 2H), 3.47 (s, 3H), 
2.37-2.28 (m, 2H), 2.14-2.09 (m, 2H), 1.42 (s, 9H). 
   
NHO
O
O(CH2)3C6F13  
R-27a 
4(R)-{4-[(3-Perfluorohexyl)propyl-1-oxy]phenyl}oxazolidinone (R-27a): To a solution of R-
34a (2.10 g, 3.43 mmol) in THF (10 mL) was added SOCl2 (1.0 mL, 13.04 mmol) dropwise via 
syringe over 10 min at 0 °C and the mixture was stirred at room temperature for 15 h. Excess 
SOCl2 was removed by rotary evaporation and the residue was dissolved in EtOAc and washed 
with water, sat. NH4Cl and brine. The organics were dried over MgSO4 and concentrated. 
Purification through column chromatography (1:1 hexanes/EtOAc) provided R-27a (1.48 g, 80%) 
as white solid: 
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mp 116-118°; [α]20D -6.08 (c = 0.17, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 8.7 Hz, 
2H), 6.94 (d, J = 8.7 Hz, 2H), 5.34 (bs, 1H), 4.95 (t, J = 7.8 Hz, 1H), 4.75 (t, J = 8.6 Hz, 1H), 
4.20 (dd, J = 7.0, 8.6 Hz, 1H), 4.08 (t, J = 5.8 Hz, 2H), 2.41 (m, 2H), 2.17 (m, 2H); 13C NMR 
(125 MHz, CDCl3) δ 159.1, 159.0, 131.7, 127.5 (2C), 115.1 (2C), 72.7, 66.5, 55.9, 27.9, 20.5; IR 
(NaCl) 3294, 3054, 2987, 2306, 1747, 1713, 1614, 1515, 1479, 1423, 1261, 1142, 1031, 896, 745, 
692; LRMS (EI+) 539 (M+); HRMS (EI+) Calcd. for C18H14NO3F13 (M+) 539.0766. Found 
539.077. 
   
NHO
O
O(CH2)3C8F17  
    S-27b 
4(S)-{4-[(3-Perfluorooctyl)propyl-1-oxy]phenyl}oxazolidinone (S-27b): 
mp 126-129°; [α]20D +16.78 (c = 0.13, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.30 (d, J = 8.6 Hz, 
2H), 6.94 (d, J = 8.6 Hz, 2H), 5.33 (s, 1H), 4.95 (t, J = 7.7 Hz, 1H), 4.75 (t, J = 8.6 Hz, 1H), 4.20 
(dd, J = 7.2, 8.3 Hz, 1H), 4.08 (t, J = 5.8 Hz, 2H), 2.41 (m, 2H), 2.17 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 159.1, 159.0, 131.7, 127.5 (2C), 115.1 (2C), 72.7, 66.5, 55.9, 27.9, 20.5; IR 
(NaCl) 3295, 3054, 2987, 2305, 1745, 1713, 1615, 1588, 1515, 1479, 1423, 1402, 1265, 1167, 
1031, 896, 744, 704; LRMS (EI+) 639 (M+); HRMS (EI+) Calcd. for C20H14NO3F17 (M+) 
639.0702. Found 639.068. 
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R-28a 
4(R)-{4-[(3-Perfluorohexyl)propyl-1-oxy]phenyl}-3-propionyloxazolidinone (R-28a): To a 
solution of R-27a (0.50g, 0.93 mmol) in THF (0.9 mL) was added DMAP (11.3 mg, 0.093 mmol, 
10 mol%) and Et3N (0.13 mL, 0.94 mmol) dropwise. The mixture was kept at 0-10 °C and 
propionic anhydride (0.25 mL, 1.89 mmol) was added dropwise over 5 min. The reaction mixture 
was stirred at room temperature for 12 h and the volatiles were removed by rotary evaporation. 
The residue was washed with water, brine and dried (MgSO4). Purification through 
chromatography (1:1 hexanes/EtOAc) provided R-28a (0.48 g, 87%) as a white solid. 
mp 90-93°; [α]20D -27.00 (c = 0.20, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.28 (d, J = 8.6 Hz, 
2H), 6.91 (d, J = 8.7 Hz, 2H), 5.41 (dd, J = 3.5, 8.6 Hz, 1H), 4.71 (t, J = 8.8 Hz, 1H), 4.31 (dd, J 
= 3.6, 8.9 Hz, 1H), 4.06 (t, J = 5.8 Hz, 2H), 3.05 (m, 2H), 2.40 (m, 2H), 2.15 (m, 2H), 1.13 (t, J = 
7.3, 3H); 13C NMR (75 MHz, CDCl3) δ 173.5, 158.7, 153.7, 131.7, 127.5 (2C), 114.9 (2C), 70.1, 
66.3, 57.1, 29.2, 27.8 (t, 1C), 20.5, 8.1; IR (NaCl) 2985, 2926, 2877, 2305, 1795, 1700, 1613, 
1521, 1470, 1454, 1390, 1368, 1323, 1244, 1208, 1188, 1122, 1067, 1021, 941, 836, 757, 700; 
LRMS (EI+) 595 (M+); HRMS (EI+) Calcd. for C21H18NO4F13 (M+) 595.1028. Found 595.102. 
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S-28b 
4(S)-{4-[(3-Perfluorooctyl)propyl-1-oxy]phenyl}-3-propionyloxazolidinone (S-28b):  
mp 103-107°; [α]20D +18.61 (c = 0.18, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.28 (d, J = 8.5 Hz, 
2H), 6.91 (d, J = 8.6 Hz, 2H), 5.41 (dd, J = 3.5, 8.6 Hz, 1H), 4.71 (t, J = 8.8 Hz, 1H), 4.31 (dd, J 
= 3.5, 8.9 Hz, 1H), 4.06 (t, J = 5.8 Hz, 2H), 3.05 (m, 2H), 2.40 (m, 2H), 2.15 (m, 2H), 1.13 (t, J = 
7.3, 3H); 13C NMR (75 MHz, CDCl3) δ 173.8, 159.1, 154.0, 132.0, 127.8 (2C), 114.9 (2C), 70.4, 
66.7, 57.4, 29.5, 28.5 (t, 1C), 20.9, 8.4; IR (NaCl) 3055, 2986, 2879, 2411, 2305, 1783, 1699, 
1613, 1587, 1515, 1453, 1383, 1322, 1243, 1200, 1147, 1066, 1023, 975, 896, 831, 806, 746; 
LRMS (EI+) 695 (M+); HRMS (EI+) Calcd. for C23H18NO4F17 (M+) 695.0964. Found 695.091. 
 
NO
O O
 
R-28 
4(R)-Phenyl-3-propionyloxazolidinone (R-28): See ref. 14. 
1H NMR (300 MHz, CDCl3) δ 7.35-7.27 (m, 5H), 5.46 (dd, J = 3.6, 8.7 Hz, 1H), 4.73 (t, J = 8.8 
Hz, 1H), 4.32 (dd, J = 3.6, 8.9 Hz, 1H), 2.97 (m, 2H), 1.15 (t, J = 7.3, 3H).  
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R-36a                         R-37a 
4(R)-{4-[(3-Perfluorohexyl)propyl-1-oxy]phenyl}-3-(2S-methyl-3-
phenylpropionyl)oxazolidinone (R-36a): To a mixture of R-28a (0.05 g, 0.084 mmol) in THF 
(1.3 mL) was added lithium bis(trimethylsilyl)amide (1.0 M in THF, 0.126 mL, 0.126 mmol) 
dropwise at -78 °C under an argon atmosphere via syringe and the mixture was allowed to stir for 
30 min. Benzyl bromide (0.031 mL, 0.252 mmol) was added at -78 °C and the reaction solution 
was stirred at this temperature for 2 h. Then the mixture was warmed to room temperature over a 
further 24 h. Sat. NH4Cl was added to quench the reaction and the mixture was extracted with 
ethyl acetate (3 x 10 mL). The organics were combined and washed with brine, dried (MgSO4) 
and concentrated. Purification through column chromatography (7:3 hexanes/EtOAc) provided 
major product R-36a (0.034 g, 59%) as white solid, minor product R-37a (0.003 g, 5%) also as a 
white solid, deacylation product R-27a (0.009g, 23%) and recovered imde R-28a (0.003 g, 6%). 
R-36a is a little polar than R-37a. 
R-36a: mp 129-134°; [α]20D −14.00 (c = 0.05, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.22-7.05 (m, 
7H), 6.84 (d, J = 8.7 Hz, 2H), 5.42 (dd, J = 4.1, 8.7 Hz, 1H), 4.69 (t, J = 8.8 Hz, 1H), 4.24 (dd, J 
= 4.1, 8.9 Hz, 1H), 4.17 (m, 1H), 4.06 (t, J = 5.8 Hz, 2H), 3.07 (dd, J = 6.7, 13.2 Hz, 1H), 2.53 
(dd, J = 7.8, 13.4 Hz, 1H), 2.40 (m, 2H), 2.17 (m, 2H), 1.14 (d, J = 6.7, 3H); 13C NMR (75 MHz, 
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CDCl3) δ 176.3, 158.9, 153.6, 139.2, 131.7, 129.5 (2C), 128.6 (2C), 127.6 (2C), 126.5, 115.3 
(2C), 70.1, 66.7, 57.6, 40.0, 39.8, 28.5, 20.9, 16.5; IR (NaCl) 2924, 1759, 1704, 1514, 1455, 1387, 
1308, 1230, 1181, 1142, 1041, 1032, 993, 831, 747, 700; LRMS (ES+) 708 (M + Na+); HRMS 
(ES+) Calcd. for C28H24NNaO4F13 (M + Na+) 708.1395. Found 708.142. 
R-37a: 1H NMR (300 MHz, CDCl3) δ 7.32-7.17 (m, 7H), 6.90 (d, J = 8.8 Hz, 2H), 5.29 (dd, J = 
3.4, 8.5 Hz, 1H), 4.51 (t, J = 8.7 Hz, 1H), 4.21 (dd, J = 3.6, 8.9 Hz, 1H), 4.17 (m, 1H), 4.05 (t, J = 
5.8 Hz, 2H), 3.05 (dd, J = 7.6, 13.4 Hz, 1H), 2.68 (dd, J = 7.2, 13.4 Hz, 1H), 2.32 (m, 2H), 2.15 
(m, 2H), 1.14 (d, J = 6.8, 3H). 
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S-37b                         S-36b 
4(S)-{4-[(3-Perfluorooctyl)propyl-1-oxy]phenyl}-3-(2R-methyl-3-phenylpropionyl) 
oxazolidinone (S-37b): Purification through column chromatography (7:3 hexanes/EtOAc) 
provided major product S-37b (60%) as white solid, minor product S-36b (4%) also as a white 
solid, deacylation product S-27b (28%) and recovered imde S-28b (9%). S-37b is a little polar 
than S-36b. 
S-37b: mp 138-143°; [α]20D +2.08 (c = 0.12, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.21-7.05 (m, 
7H), 6.84 (d, J = 8.7 Hz, 2H), 5.42 (dd, J = 3.9, 8.7 Hz, 1H), 4.69 (t, J = 8.9 Hz, 1H), 4.24 (dd, J 
= 4.1, 8.9 Hz, 1H), 4.17 (m, 1H), 4.06 (t, J = 5.8 Hz, 2H), 3.07 (dd, J = 6.7, 13.3 Hz, 1H), 2.53 
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(dd, J = 7.7, 13.3 Hz, 1H), 2.41 (m, 2H), 2.16 (m, 2H), 1.13 (d, J = 6.7, 3H); 13C NMR (75 MHz, 
CDCl3) δ 176.0, 158.6, 153.4, 138.9, 131.4, 129.2 (2C), 128.3 (2C), 127.3 (2C), 126.2, 115.0 
(2C), 69.8, 66.4, 57.3, 39.7, 39.5, 28.0, 20.6, 16.2; IR (NaCl) 2923, 1758, 1704, 1514, 1387, 1308, 
1205, 1180, 1147, 1032, 993, 831, 747, 701; LRMS (ES+) 808 (M + Na+); HRMS (EI+) Calcd. for 
C30H24NO4F17 (M+) 785.1434. Found 785.144. 
S-36b: 1H NMR (300 MHz, CDCl3) δ 7.30-7.17 (m, 7H), 6.91 (d, J = 8.7 Hz, 2H), 5.29 (dd, J = 
3.4, 8.5 Hz, 1H), 4.51 (t, J = 8.7 Hz, 1H), 4.21 (dd, J = 3.5, 8.9 Hz, 1H), 4.17 (m, 1H), 4.06 (t, J = 
5.8 Hz, 2H), 3.05 (dd, J = 7.2, 13.5 Hz, 1H), 2.68 (dd, J = 7.2, 13.4 Hz, 1H), 2.34 (m, 2H), 2.15 
(m, 2H), 1.14 (d, J = 6.8, 3H). 
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R-36                                  R-37 
4(R)-Phenyl-3-(2S-methyl-3-phenylpropionyl)oxazolidinone (R-36): Purification through 
column chromatography (7:3 hexanes/EtOAc) provided major product R-36 (62%) as white solid, 
minor product R-37 (3%) also as a white solid, deacylation product R-27 (13%) and recovered 
imide R-28 (4%). R-36 is a little polar than R-37. 
R-36: mp 110-113°; [α]20D −8.33(c = 0.27, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.32-7.08 (m, 
10H), 5.46 (dd, J = 4.1, 8.8 Hz, 1H), 4.71 (t, J = 8.8 Hz, 1H), 4.25 (dd, J = 4.1, 8.9 Hz, 1H), 4.20 
(m, 1H), 3.09 (dd, J = 6.9, 13.3 Hz, 1H), 2.56 (dd, J = 7.7, 13.3 Hz, 1H), 1.15 (d, J = 6.7, 3H); 
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13C NMR (75 MHz, CDCl3) δ 175.9, 153.3, 138.8, 129.1 (3C), 129.0 (2C), 128.6, 128.4 (2C), 
126.2, 125.7 (2C), 69.7, 57.6, 40.2, 39.6, 16.2; IR (NaCl) 2923, 1758, 1704, 1514, 1455, 1387, 
1308, 1205, 1180, 1147, 1032, 993, 831, 747, 701; LRMS (EI+) 309 (M+); HRMS (EI+) Calcd. for 
C19H19NO3 (M+) 309.1365. Found 309.136. 
R-37: See ref. 35. 
1H NMR (300 MHz, CDCl3) δ 7.41-7.21 (m, 10H), 5.33 (dd, J = 3.6, 8.8 Hz, 1H), 4.53 (t, J = 8.7 
Hz, 1H), 4.21-4.16 (m, 2H), 3.05 (dd, J = 7.8, 13.4 Hz, 1H), 2.69 (dd, J = 7.2, 13.5 Hz, 1H), 1.16 
(d, J = 6.8, 3H). 
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R-38a 
4(R)-{4-[(3-Perfluorohexyl)propyl-1-oxy]phenyl}-3-(2R-methyl-3S-hydroxy-5-phenyl- 
propionyl)oxazolidinone (R-38a): To a solution of R-28a (0.10g, 0.168 mmol) in CH2Cl2 at 0 °C 
was added dropwise Bu2BOTf (1.0 M in CH2Cl2, 0.20 mL, 0.200 mmol) followed by the 
dropwise addition of DIPEA (0.04 mL, 0.22 mL). The reaction mixture was stirred for 1 h at 0 °C 
and then cooled to −78 °C. Thereafter, freshly distilled hydrocinnamaldehyde (0.04 mL, 0.252 
mmol) was added dropwise and the reaction mixture was stirred at −78 °C for 1 h. The reaction 
mixture was warmed to room temperature over 1 h and stirred at the same temperature for 2 h. 
Then it was cooled to 0 °C and 0.8 mL of the mixture of pH 7 phosphate buffer and methanol 
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(1:3) was added. The resulting cloudy solution was then treated with 0.6 mL of a mixture of 
methanol and 30% H2O2 (2:1) via syringe at such a rate so as to keep the temperature below 10 
°C. The solution was stirred for 1 h and the volatile material was removed with a rotary 
evaporator. The resulting mixture was diluted with EtOAc and the organic layer was washed with 
5% aq. HCl solution, aq. NaHCO3 solution, brine, dried (MgSO4), filtered and concentrated to 
give the crude product. Purification by flash chromatography (7:3 hexanes/EtOAc) provided R-
38a (0.050g, 38%) as white solid and recovered starting imide (0.055 g, 55%). 
mp 79-84°; [α]20D −3.86 (c = 0.43, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.30-7.15 (m, 7H), 6.92 
(d, J = 8.5 Hz, 2H), 5.40 (dd, J = 3.8, 8.7 Hz, 1H), 4.69 (t, J = 8.8 Hz, 1H), 4.27 (dd, J = 3.8, 8.9 
Hz, 1H), 4.05 (t, J = 5.8, 2H), 3.96 (m, 1H), 3.80 (m, 1H), 2.86-2.80 (m, 2H), 2.71-2.67 (m, 1H), 
2.33-2.28 (m, 2H), 2.14-2.10 (m, 2H), 1.91-1.86 (m, 1H), 1.68-1.66 (m, 1H), 1.17 (d, J = 7.1, 3H); 
13C NMR (75 MHz, CDCl3) δ 177.1, 158.9, 153.2, 141.8, 131.3, 128.5 (2C), 128.3 (2C), 127.2 
(2C), 125.8, 115.1 (2C), 70.3, 70.0, 66.4, 57.1, 42.3, 35.4, 32.1, 27.9, 20.6, 10.4; IR (NaCl) 3512, 
3063, 3028, 2944, 2880, 1782, 1705, 1613, 1587, 1516, 1497, 1454, 1385, 1319, 1247, 1204, 
1145, 1122, 1030, 953, 835, 812, 747, 733, 699, 653; LRMS (EI+) 729 (M+); HRMS (EI+) Calcd. 
for C30H28NO5F13 (M+) 729.1760. Found 729.172. 
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S-39b 
4(S)-{4-[(3-Perfluorooctyl)propyl-1-oxy]phenyl}-3-(2S-methyl-3R-hydroxy-5-phenyl- 
propionyl)oxazolidinone (S-39b): 53 % yield of S-39b was and 40% of starting material was 
recovered. 
mp 105-109°; [α]20D +34.61 (c = 0.38, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.32-7.21 (m, 7H), 
6.92 (d, J = 8.6 Hz, 2H), 5.41 (dd, J = 3.8, 8.7 Hz, 1H), 4.70 (t, J = 8.9 Hz, 1H), 4.27 (dd, J = 3.9, 
8.9 Hz, 1H), 4.06 (t, J = 5.8, 2H), 3.97 (m, 1H), 3.80 (m, 1H), 2.88-2.80 (m, 2H), 2.73-2.63 (m, 
1H), 2.35-2.26 (m, 2H), 2.14-2.09 (m, 2H), 1.92-1.86 (m, 1H), 1.73-1.66 (m, 1H), 1.18 (d, J = 7.1, 
3H); 13C NMR (75 MHz, CDCl3) δ 177.1, 158.9, 153.2, 141.9, 131.3, 128.5 (2C), 128.4 (2C), 
127.2 (2C), 125.8, 115.1 (2C), 70.3, 70.0, 66.4, 57.1, 42.3, 35.4, 32.1, 28.0, 20.6, 10.4; IR (NaCl) 
3521, 3027, 2922, 1782, 1705, 1614, 1515, 1454, 1385, 1248, 1152, 1031, 983, 834, 812, 738, 
703, 656; LRMS (ES+) 852 (M + Na+); HRMS (ES+) Calcd. for C32H28NNaO5F17 (M + Na+) 
852.1594. Found 852.160. 
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R-38 
(R)-Phenyl-3-(2R-methyl-3S-hydroxy-5-phenylpropionyl)oxazolidinone (R-38): 81% of R-38 
was isolated and 7% of starting material was recovered. 
1H NMR (300 MHz, CDCl3) δ 7.55-7.12 (m, 10H), 5.39 (dd, J = 4.0, 8.7 Hz, 1H), 4.66 (t, J = 8.9 
Hz, 1H), 4.21 (dd, J = 4.0, 8.9 Hz, 1H), 3.92-3.86 (m, 1H), 3.77-3.69 (m, 1H), 2.83-2.80 (m, 1H), 
2.78-2.73 (m, 1H), 2.66-2.56 (m, 1H), 1.89-1.76 (m, 2H), 1.13 (d, J = 7.1, 3H);  
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